What docking and QSAR tell us about design of HIV-1 reverse transcryptase nonnucleoside inhibitors

„What docking and QSAR tell us about design of HIV-1 reverse transcryptase nonnucleoside inhibitors?” Agata Paneth, Wojciech Płonka, Piotr Paneth J. Mol. Mod. 23, 317 (2017)

E-mail jest niepoprawny